secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2022-12-12T23:59:59+00:00
Accession:  0001193125-22-302736
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte appoints Elvia Cowan as principal accounting officer effective Jan 1, 2023
--------------------------------------------------------------------------------

- Elvia Cowan, 50, currently SVP Finance since July 2022, appointed principal accounting officer.
- Previously VP Controller at 23andMe (Oct 2018 - Mar 2022) and CFO at Ruby Ribbon.
- Andrew Guggenhime remains President and CFO, stepping down as principal accounting officer.
- Cowan is a CPA in California and holds a B.A. in Business Administration from Mount Saint Mary's University.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312522302736/0001193125-22-302736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312522302736/d304365d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-302736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer